Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
OncoSec Medical (United States)
Homepage:
oncosec.com
Alternate names:
OncoSec Medical,
OncoSec Medical Incorporated
ROR:
05wbtqy13
OpenAlex ID:
I4405282461
Works
49
Awards
1
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
2020
·
Alain P. Algazi
, Christopher G. Twitty
, et al.
·
Clinical Cancer Research
·
170
Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
2020
·
A. Algazi
, S. Bhatia
, et al.
·
Annals of Oncology
·
144
PDF
Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue
2016
·
Marisa Dolled-Filhart
, Darren Locke
, et al.
·
Archives of Pathology & Laboratory Medicine
·
97
In-situ tumor vaccination: Bringing the fight to the tumor
2015
·
Robert H Pierce
, Jean S Campbell
, et al.
·
Human Vaccines & Immunotherapeutics
·
82
PDF
Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy
2018
·
Anandaroop Mukhopadhyay
, Jocelyn Wright
, et al.
·
Gene Therapy
·
59
PDF
Melanoma Treatment with Intratumoral Electroporation of Tavokinogene Telseplasmid (pIL-12, Tavokinogene Telseplasmid)
2017
·
David A Canton
, Shawna Shirley
, et al.
·
Immunotherapy
·
59
PDF
Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters
2018
·
C. Burkart
, A. Mukhopadhyay
, et al.
·
Gene Therapy
·
33
Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma.
2014
·
Adil Daud
, Alain Patrick Algazi
, et al.
·
Journal of Clinical Oncology
·
33
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
2022
·
Jack Y. Lee
, Bianca Nguyen
, et al.
·
Molecular Therapy — Oncolytics
·
22
PDF
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
2024
·
Ahmad A. Tarhini
, Zeynep Eroglu
, et al.
·
Clinical Cancer Research
·
19
PDF
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
2016
·
Sonja Althammer
, Keith Steele
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
CXCL7 aggravates the pathological manifestations of neuromyelitis optica spectrum disorder by enhancing the inflammatory infiltration of neutrophils, macrophages and microglia
2022
·
Zhuhe Liu
, Yuanyuan Wang
, et al.
·
Clinical Immunology
·
16
Abstract P3-09-04: Phase 2, open-label study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation in combination with intravenous pembrolizumab therapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (mTNBC) (KEYNOTE- 890/OMS-I141)
2020
·
Melinda L. Telli
, Irene Wapnir
, et al.
·
Cancer Research
·
13
Development of an adaptive electroporation system for intratumoral plasmid DNA delivery
2018
·
Douglas W. Brown
, Arya J. Bahrami
, et al.
·
Bioelectrochemistry
·
11
Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)
2015
·
Adil Daud
, Alain Algazi
, et al.
·
Journal of Translational Medicine
·
11
PDF
Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model
2019
·
Eiichi Ishida
, Jina Lee
, et al.
·
Cancer Immunology Immunotherapy
·
10
799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data
2020
·
Pablo Fernandez-Penas
, Matteo Carlino
, et al.
·
Journal for ImmunoTherapy of Cancer
·
9
Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma
2015
·
Adil Daud
, Kathryn Toshimi Takamura
, et al.
·
Journal of Translational Medicine
·
9
PDF
480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12
2020
·
Shawn Jensen
, Christopher Twitty
, et al.
·
Journal for ImmunoTherapy of Cancer
·
6
PDF
Immune monitoring outcomes of patients with stage III/IV melanoma treated with a combination of pembrolizumab and intratumoral plasmid interleukin 12 (pIL-12).
2017
·
Alain Patrick Algazi
, Katy K. Tsai
, et al.
·
Journal of Clinical Oncology
·
6
Abstract CT134: Intratumoral electroporation of plasmid IL-12 can prime response to anti-PD1/PD-L1 blockade in patients with Stage III/IV-M1a melanoma
2016
·
Alain Algazi
, Katy K. Tsai
, et al.
·
Cancer Research
·
6
383 Durable responses with intratumoral electroporation of plasmid interleukin 12 plus pembrolizumab in patients with advanced melanoma progressing on an anti-PD-1 antibody: updated data from keynote 695
2021
·
Pablo Fernandez-Penas
, Matteo Carlino
, et al.
·
Journal for ImmunoTherapy of Cancer
·
5
PDF
Delivery of Cytokines Using Gene Electrotransfer
2017
·
Shawna A. Shirley
·
Springer eBooks
·
5
Intratumoral Delivery of Immune Therapy and Gene Therapy: The Next Era for Cancer Therapy
2023
·
Vincent M Wu
, Robert H Arch
, et al.
·
Immunotherapy
·
4
1093P Neoadjuvant (NeoAd) intratumoral (IT) TAVO-EP (plasmid IL-12 electro gene transfer) in combination with nivolumab (NIVO) for patients (pts) with operable locoregionally advanced melanoma
2023
·
A. Tarhini
, Z. Eroglu
, et al.
·
Annals of Oncology
·
3
PDF
Show more works
View as search
Works count:
49
Citation count:
869
Year
Topic
Type